Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response

被引:4
|
作者
Varese, Augusto [1 ,2 ]
Mazzitelli, Bianca [1 ,2 ]
Erra Diaz, Fernando [1 ,2 ]
Kjolhede, Maria Victoria [1 ,2 ]
Ojeda, Diego [3 ]
Vellicce, Alejandra [4 ]
Arto, Penelope [4 ]
Cicero, Carla [4 ]
Pascowski, Maria [5 ]
Figueras, Laura [6 ]
Broese, Barbara [6 ]
Davila, Rosa [7 ]
Zarlenga, Rocio [1 ,2 ]
Rivelli, Federico [1 ,2 ]
Verruno, Camila [1 ,2 ]
Silenzi, Valeria [1 ,2 ]
Beltran, Ivana [1 ,2 ]
Gamarnik, Andrea [3 ]
Ceballos, Ana [1 ,2 ]
Zala, Carlos [6 ]
Badolati, Adelina [5 ]
Geffner, Jorge [1 ,2 ]
机构
[1] Univ Buenos Aires, Fac Med, Inst Invest Biomed Retrovirus, Paraguay 2155 Piso 11,C1121 ABG, Buenos Aires, DF, Argentina
[2] Consejo Nacl Invest Cient & Tecn, SIDA, Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, Fundacien Inst Leloir, Buenos Aires, DF, Argentina
[4] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina
[5] Hosp Alejandro Posadas, Buenos Aires, DF, Argentina
[6] Hosp Cent San Isidro Melchor A Posse, Buenos Aires, DF, Argentina
[7] Hosp Villa Mercedes Juan Domingo Peron, San Luis, Argentina
来源
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 10期
关键词
COVID-19; SARS-CoV-2; Omicron; neutralizing antibodies;
D O I
10.1093/infdis/jiac250
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is usually asymptomatic or mild and appears to be poorly immunogenic at least in unvaccinated individuals. Here, we found that health care workers vaccinated with 2 doses of Sputnik V and a booster dose of ChAdOx1 mount a vigorous neutralizing-antibody response after Omicron breakthrough infection. Breakthrough infections with SARS-CoV-2 Omicron are seen with increasing frequency. We found that Omicron breakthrough infection after heterologous vaccination with 2 doses of Sputnik V and a booster dose of ChAdOx1 induces a strong neutralizing response against Omicron.
引用
收藏
页码:1717 / 1720
页数:4
相关论文
共 50 条
  • [21] Heterologous prime-boost vaccination with a peptidebased vaccine and viral vector improves antitumor therapy
    Alfei, F.
    Belnoue, E.
    Rossi, M.
    Derouazi, M.
    Devy-Dimanche, L.
    Santiago-Raber, M. L.
    SWISS MEDICAL WEEKLY, 2023, 153 : 10S - 10S
  • [22] Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines
    Hu, Zhidong
    Jiang, Weimin
    Gu, Ling
    Qiao, Dan
    Shu, Tsugumine
    Lowrie, Douglas B.
    Lu, Shui-Hua
    Fan, Xiao-Yong
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (12): : 1685 - 1694
  • [23] A prime-boost vaccination of mice with heterologous H5N1 strains
    Ikeno, Daisuke
    Kimachi, Kazuhiko
    Kudo, Yasuhiro
    Goto, Shuro
    Itamura, Shigeyuki
    Odagiri, Takato
    Tashiro, Masato
    Kino, Yoichiro
    VACCINE, 2009, 27 (23) : 3121 - 3125
  • [24] Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis
    Dondji, B
    Pérez-Jimenez, E
    Goldsmith-Pestana, K
    Esteban, M
    McMahon-Pratt, D
    INFECTION AND IMMUNITY, 2005, 73 (08) : 5286 - 5289
  • [25] Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines
    Zhidong Hu
    Weimin Jiang
    Ling Gu
    Dan Qiao
    Tsugumine Shu
    Douglas B. Lowrie
    Shui-Hua Lu
    Xiao-Yong Fan
    Journal of Molecular Medicine, 2019, 97 : 1685 - 1694
  • [26] A Comparative Approach between Heterologous Prime-Boost Vaccination Strategy and DNA Vaccinations for Rabies
    Borhani, Kiandokht
    Ajorloo, Mehdi
    Bamdad, Taravat
    Mozhgani, Sayed Hamid Reza
    Ghaderi, Mostafa
    Gholami, Ali Reza
    ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (04) : 223 - 227
  • [27] Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? COMMENT
    Choudhary, Om Prakash
    Priyanka
    Ahmed, Jivan Q.
    Mohammed, Teroj A.
    Singh, Indraj
    Rodriguez-Morales, Alfonso J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5135 - 5138
  • [28] Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas
    Ruhl, Julia
    Citterio, Carmen
    Engelmann, Christine
    Haigh, Tracey
    Dzionek, Andrzej
    Dreyer, Johannes
    Khanna, Rajiv
    Taylor, Graham S.
    Wilson, Joanna B.
    Leung, Carol S.
    Munz, Christian
    JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (05): : 2071 - 2087
  • [29] Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model
    Wang, Lei
    Sun, Ximeng
    Huang, Jingjing
    Zhan, Bin
    Zhu, Xinping
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [30] Role of LFA-1 for protective immunity elicited by heterologous prime-boost vaccination against intracellular parasitic infection
    Vasconcelos, Jose Ronnie
    Ferreira, Camila Pontes
    Rodrigues, Mauricio
    JOURNAL OF IMMUNOLOGY, 2015, 194